These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16176495)

  • 61. A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China.
    Cui M; Tu CC; Chen EZ; Wang XL; Tan SC; Chen C
    Adv Ther; 2016 Sep; 33(9):1600-11. PubMed ID: 27397588
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Creative cost-effectiveness analysis of CAPRIE data- dust in our eyes.
    Eriksson P
    Am J Med; 2005 Feb; 118(2):199-200; author reply 200. PubMed ID: 15694910
    [No Abstract]   [Full Text] [Related]  

  • 64. Antiplatelet agents for secondary prevention of ischemic stroke.
    Majid A; Delanty N; Kantor J
    Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Cost-effectiveness of clopidogrel vs. aspirin treatment in high-risk acute coronary syndrome patients in Denmark].
    Heeg B; van Gestel A; Hout Bv; Olsen J; Haghfelt TH
    Ugeskr Laeger; 2006 Aug; 168(35):2911-5. PubMed ID: 16982022
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
    Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ
    Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE].
    Alvarez-Sabín J; Montaner-Villalonga J
    Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke].
    Claes C; Mittendorf T; Grond M; von der Schulenburg JM
    Med Klin (Munich); 2008 Nov; 103(11):778-87. PubMed ID: 19165429
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Calculation of costs of stroke, cost effectiveness of stroke units and secondary prevention in patients after a stroke, as recommended by revised CBO practice guideline 'Stroke'].
    Niessen LW; Dippel DW; Limburg M
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1959-64. PubMed ID: 11048560
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.
    Lenz T; Wilson A
    Clin Pharmacokinet; 2003; 42(10):909-20. PubMed ID: 12885264
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aggrenox: an aspirin and extended-release dipyridamole combination.
    Wong NN
    Heart Dis; 2001; 3(5):340-6. PubMed ID: 11975816
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clopidogrel in the management of cerebrovascular events.
    Ringleb PA; Schellinger PD; Schwark C
    Int J Clin Pract; 2004 Apr; 58(4):402-10. PubMed ID: 15161127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany.
    Brüggenjürgen B; Lindgren P; Ehlken B; Rupprecht HJ; Willich SN
    Eur J Health Econ; 2007 Mar; 8(1):51-7. PubMed ID: 17186199
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CAPRIE trial.
    Barer D
    Lancet; 1997 Feb; 349(9048):355-6. PubMed ID: 9024397
    [No Abstract]   [Full Text] [Related]  

  • 77. Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France.
    Marissal JP; Selke B
    Pharmacoeconomics; 2004; 22(10):661-70. PubMed ID: 15244491
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke.
    Takabayashi N; Murata K; Tanaka S; Kawakami K
    Pharmacoeconomics; 2015 Oct; 33(10):1091-100. PubMed ID: 25995130
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antiplatelet drugs in the secondary prevention after stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.
    Ariesen MJ; Algra A; Kappelle LJ
    Stroke; 2006 Jan; 37(1):134-8. PubMed ID: 16306466
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
    Diener HC; Sacco RL; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; VanderMaelen C; Voigt T; Weber M; Yoon BW;
    Lancet Neurol; 2008 Oct; 7(10):875-84. PubMed ID: 18757238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.